The Retain Your Brain Health Study (RetainYourBrain.com)
NCT ID: NCT06027320
Last Updated: 2024-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
992 participants
INTERVENTIONAL
2023-12-07
2024-09-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will visit RetainYourBrain.com to answer questions about their risk factors for AD and take online word recall and card game cognitive tests. Researchers will track progress over time and compare different strategies of Alzheimer's education to see if it is possible to protect brain health, reduce Alzheimer's risk, and improve memory function.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The BrainHealth Project
NCT04869111
Brain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention
NCT05027789
Compensatory Training to Support Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease
NCT04118985
Brain Health Together: Development and Pilot Test
NCT06914947
A Comparison of Two Approaches to Developing Brain Health Programs
NCT04822129
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators created a cell phone-based online software application to provide automated, individualized monitoring and education at broad scale. The goal of the software is to function as a digital therapeutic to identify individual risk factors, assess memory and cognitive function over time, and provide education to people with a family history of AD. The system maintains bi-directional communication via text message to verify participant engagement.
Potential participants who visit our study website (www.RetainYourBrain.com) will be directed to answer questions assessing eligibility criteria. Participants who are eligible are asked to electronically sign an informed consent form, complete baseline assessments, and take online word recall and card game cognitive tests. Participants will then be randomized to one of two groups using different strategies for AD risk assessment education. Researchers will track progress over six months and compare different strategies of education to determine if it is possible to protect brain health, reduce Alzheimer's risk, and improve memory function.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Brain Health Education Arm
Subjects will receive an Alzheimer's risk assessment, memory testing, and brain health education, in addition to text message communication.
Brain Health Education
Subjects will receive an Alzheimer's risk assessment, memory testing, and brain health education, in addition to text message communication.
Alzheimer Disease Education Arm
Subjects will receive an Alzheimer's risk assessment, memory testing, and general education about Alzheimer's disease, in addition to text message communication.
Alzheimer Disease Education
Subjects will receive an Alzheimer's risk assessment, memory testing, and general education about Alzheimer's disease, in addition to text message communication.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brain Health Education
Subjects will receive an Alzheimer's risk assessment, memory testing, and brain health education, in addition to text message communication.
Alzheimer Disease Education
Subjects will receive an Alzheimer's risk assessment, memory testing, and general education about Alzheimer's disease, in addition to text message communication.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have a family history of Alzheimer's Disease (AD)
* have a compatible phone/device (phone allowing text messages and with internet access, and/or tablet device with the same capabilities)
* a minimum of one of the following risk factors: body mass index (BMI) of \< 25 kg/m2, history of pre-diabetes/diabetes, high blood pressure, high cholesterol, smoking, low physical activity, low fish intake (\< 3 times per month), high alcohol intake (\< 7 servings per week for a women and \<14 servings a week for men), diagnosed with mild or moderate depression.
Exclusion Criteria
* other dementia
* women who are currently pregnant or who plan on becoming pregnant in the next 6 months
* BMI \<18.5 kg/m2
* consuming \>35 alcoholic drinks/week for men or \>28 alcoholic drinks/week for women
* severe depression (PHQ-9 score of more than 15)
* current treatment for cancer
* diagnosis of Parkinson's disease, amyotrophic lateral sclerosis, Lewy body dementia, frontotemporal disorders, multiple sclerosis, or other neurodegenerative disease
* current treatment for an eating disorder
* currently prescribed insulin for type I or II diabetes
* inability to give informed consent or complete identity verification
* participating in another AD trial.
53 Years
105 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Retain Health, Inc
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tammie Elgammal, MD
Role: PRINCIPAL_INVESTIGATOR
Retain Health, Inc
Robert Krikorian, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Cincinnati School of Medicine
Mark McInnis, BA
Role: PRINCIPAL_INVESTIGATOR
Retain Health, Inc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Retain Health, Inc.
Bedford, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
RetainYourBrain Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20216157
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.